PL2038288T3 - Nowe pochodne kwasu 4-amino-3-(-azolilofenoksymetylo)tieno[3,2-c]pirydyno-7-karboksylowego - Google Patents

Nowe pochodne kwasu 4-amino-3-(-azolilofenoksymetylo)tieno[3,2-c]pirydyno-7-karboksylowego

Info

Publication number
PL2038288T3
PL2038288T3 PL07730300T PL07730300T PL2038288T3 PL 2038288 T3 PL2038288 T3 PL 2038288T3 PL 07730300 T PL07730300 T PL 07730300T PL 07730300 T PL07730300 T PL 07730300T PL 2038288 T3 PL2038288 T3 PL 2038288T3
Authority
PL
Poland
Prior art keywords
thienoý3
azolyl
phenoxymethyl
pyridine
amino
Prior art date
Application number
PL07730300T
Other languages
English (en)
Inventor
Yi Chen
Kin-Chun Thomas Luk
Pamela Loreen Rossman
Sung-Sau So
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL2038288T3 publication Critical patent/PL2038288T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PL07730300T 2006-06-29 2007-06-22 Nowe pochodne kwasu 4-amino-3-(-azolilofenoksymetylo)tieno[3,2-c]pirydyno-7-karboksylowego PL2038288T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81761606P 2006-06-29 2006-06-29
EP07730300A EP2038288B1 (en) 2006-06-29 2007-06-22 Novel 4-amino-3-(-azolyl-phenoxymethyl)-thienoý3,2¨pyridine-7-carboxylic acid derivatives
PCT/EP2007/056241 WO2008000697A1 (en) 2006-06-29 2007-06-22 Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
PL2038288T3 true PL2038288T3 (pl) 2011-05-31

Family

ID=38514272

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07730300T PL2038288T3 (pl) 2006-06-29 2007-06-22 Nowe pochodne kwasu 4-amino-3-(-azolilofenoksymetylo)tieno[3,2-c]pirydyno-7-karboksylowego

Country Status (16)

Country Link
US (1) US7932390B2 (pl)
EP (1) EP2038288B1 (pl)
JP (1) JP4933617B2 (pl)
KR (1) KR101143286B1 (pl)
CN (1) CN101479278B (pl)
AT (1) ATE489391T1 (pl)
BR (1) BRPI0713041A8 (pl)
CA (1) CA2655398C (pl)
DE (1) DE602007010779D1 (pl)
DK (1) DK2038288T3 (pl)
ES (1) ES2354637T3 (pl)
IL (1) IL195897A (pl)
MX (1) MX2008016068A (pl)
PL (1) PL2038288T3 (pl)
PT (1) PT2038288E (pl)
WO (1) WO2008000697A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
MX339192B (es) 2010-03-24 2016-05-13 Amitech Therapeutic Solutions Inc Compuestos heterociclicos utiles para inhibicion de cinasa.
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Ｇｐｒ８４アンタゴニストおよびその使用
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732970B1 (fr) 1995-04-14 1997-05-16 Hoechst Schering Agrevo Sa Nouveaux derives de l'acide beta-methoxy acrylique, leur procede de preparation et leur application comme pesticides
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
EE200300247A (et) 2000-11-28 2003-10-15 Pfizer Products Inc. Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
ATE447404T1 (de) * 2002-03-29 2009-11-15 Novartis Vaccines & Diagnostic Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
AU2003270701B2 (en) 2002-10-31 2009-11-12 Amgen Inc. Antiinflammation agents
EP1620094A4 (en) 2003-05-06 2010-04-28 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
US20050020619A1 (en) 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US20050026944A1 (en) 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US7202363B2 (en) 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
MXPA06005934A (es) 2003-12-05 2006-07-06 Boehringer Ingelheim Pharma Compuestos de amida del acido 3-amino-tieno[2,3-b]piridin-2-carboxilico sustituido como inhibidores de la ikk.
US20050256154A1 (en) 2004-05-04 2005-11-17 Kin-Chun Luk 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides

Also Published As

Publication number Publication date
EP2038288A1 (en) 2009-03-25
IL195897A (en) 2016-04-21
JP2009541424A (ja) 2009-11-26
MX2008016068A (es) 2009-01-15
IL195897A0 (en) 2009-09-01
CN101479278A (zh) 2009-07-08
EP2038288B1 (en) 2010-11-24
DE602007010779D1 (en) 2011-01-05
CA2655398A1 (en) 2008-01-03
KR20090021195A (ko) 2009-02-27
CN101479278B (zh) 2011-12-07
US20080009515A1 (en) 2008-01-10
BRPI0713041A8 (pt) 2019-01-15
DK2038288T3 (da) 2011-01-03
US7932390B2 (en) 2011-04-26
ATE489391T1 (de) 2010-12-15
KR101143286B1 (ko) 2012-05-24
AU2007263770A1 (en) 2008-01-03
WO2008000697A1 (en) 2008-01-03
CA2655398C (en) 2014-07-29
PT2038288E (pt) 2011-01-12
BRPI0713041A2 (pt) 2012-04-17
ES2354637T3 (es) 2011-03-16
JP4933617B2 (ja) 2012-05-16

Similar Documents

Publication Publication Date Title
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
MX2009004766A (es) Derivados de espiroindolinona.
MX2011008176A (es) Derivados de 3,3'-espiroindolinona como agentes anticancerigenos.
TW200801000A (en) Spiroindolinone derivatives
IL205354A0 (en) Spiroindolinone derivatives
PH12013501489A1 (en) Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
IL193620A0 (en) Spiroindolinone derivatives
UA94833C2 (en) Substituted bicyclolactams
MY160424A (en) Substituted pyrrolidine-2-carboxyamides.
IL197197A0 (en) Oxindole derivatives as anticancer agents
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
TW200738695A (en) Cis-4,5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
IL208025A0 (en) Spiroindolinone derivatives
DE602004024213D1 (en) Aminopropanolderivate
TN2012000105A1 (en) Spirolactam derivatives and uses of same
TW200738627A (en) Trialkylsilyl-indoles
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
MX2009006337A (es) Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
MX2009008221A (es) Antagonista de receptor de cromeno s1p1.
IL195897A0 (en) Novel 4-amino-3-(-azolyl-phenoxymethyl)-thieno[3,2]pyridine-7-carboxylic acid derivatives
IL196418A0 (en) Thieno[3,2-c]pyridine-7-carboxylic acid derivatives
TW200744612A (en) New combination
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents